Mohammed Ibrahim Tahir

Mohammed Ibrahim Tahir

Auto-generated profile, based on publicly available information

Mohammed Ibrahim Tahir

Ahmadu Bello University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2020 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
PDF file
AAAbubakar Umar Anka
Abubakar Umar Anka
MTMohammed Ibrahim Tahir
Mohammed Ibrahim Tahir
SASharafudeen Dahiru Abubakar
Sharafudeen Dahiru Abubakar
MAMohamed Alsabbagh
Mohamed Alsabbagh
ZZZeineb Zian
Zeineb Zian
GAGholamreza Azizi
Gholamreza Azizi
SARS‐CoV‐2 is a novel human coronavirus responsible for the Coronavirus disease 2019 (COVID‐19) pandemic. Pneumonia and acute respiratory distress syndrome are the major complications of COVID‐19. SARS‐CoV‐2 infection can activate innate and adaptive immune responses and result in massive inflammatory responses later in the disease. These uncontrolled inflammatory responses may lead to local and systemic tissue damage. In patients with severe COVID‐19, eosinopenia and lymphopenia with a severe reduction in the frequency of CD4+ and CD8+ T cells, B cells and natural killer (NK) cells are a common feature. COVID‐19 severity hinges on the development of cytokine storm characterized by elevated serum levels of pro‐inflammatory cytokines. Moreover, IgG‐, IgM‐ and IgA‐specific antibodies against SARS‐CoV‐2 can be detected in most patients, along with the viral RNA, forming the basis for assays that aid in patient diagnosis. Elucidating the immunopathological outcomes due to COVID‐19 could provide potential targets for immunotherapy and are important for choosing the best clinical management by consultants. Currently, along with standard supportive care, therapeutic approaches to COVID‐19 treatment involve the use of antiviral agents that interfere with the SARS‐CoV‐2 lifecycle to prevent further viral replication and utilizing immunomodulators to dampen the immune system in order to prevent cytokine storm and tissue damage. While current therapeutic options vary in efficacy, there are several molecules that were either shown to be effective against other viruses such as HIV or show promise in vitro that could be added to the growing arsenal of agents used to control COVID‐19 severity and spread.

1 January 2026 in Journal of Public Health in Africa
Verified
Journal Article
Open access
PDF file
MTMohammed I. Tahir
Mohammed I. Tahir
OIOluwafemi T. Ige
Oluwafemi T. Ige
AAAbdurrahman E. Ahmad
Abdurrahman E. Ahmad
ZTZainab L. Tanko
Zainab L. Tanko
EPElisha Peter
Elisha Peter
MAMARYAM AMINU
MARYAM AMINU
Background: Measles is a highly contagious and vaccine-preventable viral disease that results from infection with measles virus. The clinical picture of measles may resemble rubella and other viral exanthems (fever-rash disease). Aim: This study aimed to determine the measles seropositivity rate among suspected measles cases and evidence of rubella among measles seronegative cases in the seven states of northwestern Nigeria. Setting: The data were generated from the Medical Laboratory of Yusuf Dantsoho Memorial Hospital Kaduna. The laboratory receives samples from Disease Notification and Surveillance officers of local governments of the seven states of northwestern Nigerian. Methods: The study was cross-sectional where secondary data of measles case-based surveillance were analysed. The study population comprised of individuals with suspected measles infection living in the seven states of northwestern Nigerian. Results: Out of 3090 samples tested for measles immunoglobulin M (IgM) antibodies, 1553 (50.3%) tested positive, while 1537 (49.7%) tested negative. Among the negative cases, 1521 were further tested for rubella IgM antibodies, with 157 (10.3%) testing positive. Conclusion: This high measles seropositivity is concerning considering the ease of access to measles vaccines available at every primary, secondary and even tertiary health facilities spread across northwestern Nigeria. Contribution: This study reveals that measles virus circulates with high endemicity in the region, with 50.3% serologically confirmed cases among samples from persons suspected to have measles sent for testing. Additionally, 10.3% of individuals suspected having measles but tested negative were found to test positive for rubella.